Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.72 USD | -0.89% | +2.44% | +35.68% |
04-19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
04-01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.68% | 2.43B | |
+11.95% | 87.18B | |
+7.86% | 78.95B | |
-9.94% | 55.02B | |
+24.62% | 47.3B | |
+32.88% | 46.79B | |
-26.35% | 46.35B | |
+81.33% | 42.08B | |
-6.02% | 25.86B | |
+22.71% | 22.54B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Earnings Flash (CLBT) CELLEBRITE DI Posts Q4 Revenue $93M, vs. Street Est of $85.5M